Naziv |
Akcije |
strikic, ante
Differential expression of HIF1A and its downstream target VEGFA in the main subtypes of renal cell carcinoma and their impact on patient survival // Frontiers in oncology, 2023 Nov 20 (2023), 1; 1-9. doi: 10.3389/fonc.2023.1287239 |
|
Kokeza, Josipa; Strikić, Ante; Ogorevc, Marin; Kelam, Nela; Vukoja, Martina; Dilber, Ivo; Zekić Tomaš, Sandra;
The Effect of GLUT1 and HIF-1α Expressions on Glucose Uptake and Patient Survival in Non-Small-Cell Lung Carcinoma // International journal of molecular sciences, 24 (2023), 13; 10575, 14 |
|
Ogorevc, Marin ; Strikic, Ante ; Zekic Tomas, Sandra
Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method // Biomedical reports, 15 (2021), 4; 79-79. doi: 10.3892/br.2021.1455 |
|
Saratlija Novaković, Žana ; Boban, Toni ; Boraska Jelavić, Tihana ; Omrčen, Tomislav ; Šitum, Marijan ; Ledina, Dubravka ; Strikić, Ante ; Rakuljić, Zdravka ; Vilović, Katarina ; Librenjak, Davor et al.
Results of treatment of muscle-invasive bladder cancer in University Hospital of Split: 2014-2021 // Libri oncologici : Croatian journal of oncology. 2021. str. 125-125 |
|
Majić, Ana ; Urlić, Ivan ; Pancirov, Marija ; Paparella - Karaman, Ana ; Strikić, Ante ; Ban, Marija ; Hrepić, Darijo ; Vrdoljak, Eduard
Hematotoxicity od cyclin dependent kynases 4/6 (CDK4/6) inhibitors palbociclib and ribocyclib during first 2 cycles of treatment of metastatic breast cancer – a restropective analysis in single centre // Libri oncologici : Croatian journal of oncology. 2020. str. 99-99 |
|
Ban, Marija ; Strikić, Ante ; Petrić Miše, Branka ; Vrdoljak, Eduard
Uloga inhibitora CDK4/6 u liječenju hormonski ovisnoga metastatskog raka dojke negativnog na HER2 // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 141 (2019), 1-2; 33-39. doi: 10.26800/lv-141-1-2-6 |
|
Ban, Marija ; Bajić, Željko ; Buljubašić, Matea ; Dražić, Ivanka ; Petrić Miše, Branka ; Strikić, Ante ; Božić, Maja, Ledina, Dubravka ; Vrdoljak, Eduard
Correlation of the progression free survival after 1st treatment line (PFS1) with overall survival (OS) changes in metastatic breast cancer (MBC): Retrospective cohort study. 2018. str. 53-57 |
|
Klinička onkologija, 3. obnovljeno i dopunjeno izdanje / Vrdoljak, Eduard ; Belac Lovasić, Ingrid ; Kusić, Zvonko et al. (ur.)
Zagreb: Medicinska naklada, 2018 |
|
Ban, Marija ; Dražić, Ivanka ; Buljubašić, Matea ; Bajić, Željko ; Petrić Miše, Branka ; Strikić, Ante ; Božić, Maja ; Ledina, Dubravka ; Vrdoljak, Eduard
Differences in the overall survival (OS) of primary and secondary metastatic breast cancer (MBC) patients: A retrospective study. 2018. str. 50-52 |
|
Ban, Marija ; Viculin, Jelena ; Tomić, Snježana ; Čapkun, Vesna ; Strikić, Ante ; Petrić Miše, Branka ; Utrobičić, Ivo ; Vrdoljak, Eduard
Retrospective analysis of efficacy of trastuzumab in adjuvant treatment of HER 2 positive early breast cancer – single institution experience // 12th Central European Oncology Congress: Abstract Book. -: -, 2016. str. 75-75 |
|